METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0
METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0
Regular price
$158.00 USD
Sale price
$158.00 USD
Regular price
Unit price
per
Shipping calculated at checkout.
METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0
METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0
Regular price
$158.00 USD
Sale price
$158.00 USD
Regular price
Unit price
per
Shipping calculated at checkout.
Description
CaviWipes™ 2.0
The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. Fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim.
- Proven effective against SARS-CoV-2 on hard non-porous surfaces
- On EPA List Q*
- Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs
- Enhanced Efficacy Claims - Effective against 60 relevant pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
- Excellent Material Compatibility - Compatible with most non-porous, hard surfaces commonly used in clinical settings
- Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more
- 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)
2 Minute Efficacy Against
Non-Enveloped Viruses
- Adenovirus Type 2
- Echovirus Type 11
- Enterovirus Type 71
- Human Rotavirus
- Norovirus
- Adenovirus Type 5
- Rhinovirus Type 1A
Pathogenic Fungi
- Candida auris
Multi Drug-Resistant Bacteria
- Penicillin-Resistant Streptococcus pneumoniae (PRSP)
- Vancomycin-Resistant Enterococcus faecalis (VRE)
- Methicillin-Resistant Staphylococcus aureus (MRSA)
- Carbapenem-resistant Klebsiella pneumoniae (CRKP)
- Multidrug-Resistant Acinetobacter baumannii (MRAB)
- NDM-1 Enterobacter cloacae
- Vancomycin-Intermediate Staphylococcus aureus (VISA)
- Methicillin-Resistant Staphylococcus epidermidis
- Multi-Drug Resistant Pseudomonas aeruginosa
- ESBL Klebsiella pneumoniae
- ESBL Escherichia coli
Bacteria
- Acinetobacter baumannii
- Bordetella pertussis
- Burkholderia cepacia
- Enterococcus faecium
- Escherichia coli O157:H7
- Klebsiella pneumoniae
- Legionella pneumophila
- Micrococcus luteus
- Moraxella catarrhalis
- Pseudomonas aeruginosa
- Salmonella enterica
- Staphylococcus aureus
- Stenotrophomonas maltophilia
- Streptococcus mutans
- Streptococcus pyogenes
- Klebsiella aerogenes
- Serratia marcescens
- Campylobacter jejuni
- Listeria monocytogenes
- Shigella dysenteriae
- Chlamydophila pneumoniae
- Flavobacterium columnare
- Mycobacterium tuberculosis (TB)
Enveloped Viruses
- Herpes simplex virus Type 1
- Herpes simplex virus Type 2
- lnfluenza A virus
- Varicella-zoster virus
- Cytomegalovirus
- SARS-associated Coronavirus
- SARS-CoV-2
- SARS-CoV-2 – UK Variant
- SARS-CoV-2 – South African Variant
- SARs-CoV-2 – California Variant
- SARS-CoV-2 – Delta Variant
- lnfluenza B virus
- Parainfluenza virus Type 3
- Human orthopneumovirus
- Measles virus
- Hepatitis C Virus (HCV)
- Hepatitis B Virus (HBV)
- Human lmmunodeficiency Virus Type 1 (HIV-1)
Talk to Us
- Choosing a selection results in a full page refresh.